StockNews.com upgraded shares of Viking Therapeutics (NASDAQ:VKTX – Free Report) to a sell rating in a report issued on Thursday morning. A number of other equities analysts have also weighed in on the company. Oppenheimer upped their price objective on Viking Therapeutics from $116.00 to $138.00 and gave the stock an outperform rating in a […]
Viking Therapeutics (NASDAQ:VKTX – Get Free Report) released its quarterly earnings results on Wednesday. The biotechnology company reported ($0.26) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.27) by $0.01, Briefing.com reports. During the same quarter in the previous year, the company posted ($0.25) EPS. Viking Therapeutics Trading Up 7.9 % […]
Viking Therapeutics (NASDAQ:VKTX – Get Free Report) announced its quarterly earnings data on Wednesday. The biotechnology company reported ($0.26) EPS for the quarter, beating analysts’ consensus estimates of ($0.27) by $0.01, Briefing.com reports. During the same period in the previous year, the company posted ($0.25) earnings per share. Viking Therapeutics Trading Up 0.5 % Shares […]
Viking Therapeutics (NASDAQ:VKTX – Get Free Report) released its earnings results on Wednesday. The biotechnology company reported ($0.26) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.27) by $0.01, Briefing.com reports. During the same quarter in the previous year, the firm earned ($0.25) earnings per share. Viking Therapeutics Price Performance Shares of […]
Viking Therapeutics, Inc. (NASDAQ:VKTX – Get Free Report) shares traded up 1.8% during mid-day trading on Wednesday following a better than expected earnings announcement. The stock traded as high as $67.78 and last traded at $66.13. 904,840 shares were traded during mid-day trading, a decline of 84% from the average session volume of 5,629,811 shares. […]